Summary
Enovis announced a binding offer valuing eCential Robotics at €155 million, with completion expected around the end of 2026 subject to customary approvals. eCential develops robotic-assisted surgery systems and enabling technologies for spine and orthopaedic procedures.
Why it matters
The deal would bring surgical robotics into a larger medical-technology portfolio and provide another example of AI-enabled physical systems moving through mainstream healthcare consolidation.
Related coverage
- Physical Superintelligence launches $58 million physics-discovery lab
- Workplace generative AI adoption is widespread but shallow
- Visko opens Orbis, a real-time interactive world model